EP1140897A4 - Protease inhibitoren - Google Patents
Protease inhibitorenInfo
- Publication number
- EP1140897A4 EP1140897A4 EP99968936A EP99968936A EP1140897A4 EP 1140897 A4 EP1140897 A4 EP 1140897A4 EP 99968936 A EP99968936 A EP 99968936A EP 99968936 A EP99968936 A EP 99968936A EP 1140897 A4 EP1140897 A4 EP 1140897A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- protease inhibitors
- protease
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11414398P | 1998-12-23 | 1998-12-23 | |
| US114143P | 1998-12-23 | ||
| PCT/US1999/030602 WO2000039115A1 (en) | 1998-12-23 | 1999-12-21 | Protease inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1140897A1 EP1140897A1 (de) | 2001-10-10 |
| EP1140897A4 true EP1140897A4 (de) | 2002-04-03 |
Family
ID=22353596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP99968936A Withdrawn EP1140897A4 (de) | 1998-12-23 | 1999-12-21 | Protease inhibitoren |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1140897A4 (de) |
| JP (1) | JP2002533452A (de) |
| AR (1) | AR021970A1 (de) |
| AU (1) | AU2713100A (de) |
| CO (1) | CO5180541A1 (de) |
| DZ (1) | DZ2976A1 (de) |
| HK (1) | HK1041690A1 (de) |
| PE (1) | PE20001355A1 (de) |
| WO (1) | WO2000039115A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
| US6583137B1 (en) | 1999-11-10 | 2003-06-24 | Smithkline Beecham Corporation | Protease inhibitors |
| US6596715B1 (en) | 1999-11-10 | 2003-07-22 | Smithkline Beecham Corporation | Protease inhibitors |
| EP1229914A4 (de) | 1999-11-10 | 2004-06-23 | Smithkline Beecham Corp | Proteasehemmer |
| AU4344101A (en) | 2000-03-21 | 2001-10-03 | Smithkline Beecham Corp | Protease inhibitors |
| US6982263B2 (en) | 2001-06-08 | 2006-01-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Nitriles useful as reversible inhibitors of cysteine proteases |
| WO2003075853A2 (en) | 2002-03-08 | 2003-09-18 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| EP1796793A4 (de) * | 2004-09-07 | 2009-08-05 | Smithkline Beecham Corp | Neue verbindungen |
| JP5236293B2 (ja) * | 2005-01-13 | 2013-07-17 | ブリストル−マイヤーズ スクイブ カンパニー | Xia因子阻害剤としての置換ビアリール化合物 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998005336A1 (en) * | 1996-08-08 | 1998-02-12 | Smithkline Beecham Corporation | Inhibitors of cysteine protease |
| WO1998050534A1 (en) * | 1997-05-08 | 1998-11-12 | Smithkline Beecham Corporation | Protease inhibitors |
-
1999
- 1999-12-16 CO CO99078651A patent/CO5180541A1/es not_active Application Discontinuation
- 1999-12-21 AR ARP990106647A patent/AR021970A1/es unknown
- 1999-12-21 AU AU27131/00A patent/AU2713100A/en not_active Abandoned
- 1999-12-21 EP EP99968936A patent/EP1140897A4/de not_active Withdrawn
- 1999-12-21 HK HK02101209.3A patent/HK1041690A1/zh unknown
- 1999-12-21 WO PCT/US1999/030602 patent/WO2000039115A1/en not_active Ceased
- 1999-12-21 JP JP2000591026A patent/JP2002533452A/ja not_active Withdrawn
- 1999-12-22 DZ DZ990276A patent/DZ2976A1/xx active
- 1999-12-23 PE PE1999001311A patent/PE20001355A1/es not_active Application Discontinuation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998005336A1 (en) * | 1996-08-08 | 1998-02-12 | Smithkline Beecham Corporation | Inhibitors of cysteine protease |
| WO1998050534A1 (en) * | 1997-05-08 | 1998-11-12 | Smithkline Beecham Corporation | Protease inhibitors |
Non-Patent Citations (1)
| Title |
|---|
| See also references of WO0039115A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| HK1041690A1 (zh) | 2002-07-19 |
| EP1140897A1 (de) | 2001-10-10 |
| PE20001355A1 (es) | 2001-01-28 |
| AU2713100A (en) | 2000-07-31 |
| WO2000039115A1 (en) | 2000-07-06 |
| JP2002533452A (ja) | 2002-10-08 |
| AR021970A1 (es) | 2002-09-04 |
| DZ2976A1 (fr) | 2004-03-15 |
| CO5180541A1 (es) | 2002-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL349192A1 (en) | Protease inhibitors | |
| IL131661A0 (en) | Protease inhibitors | |
| PL336589A1 (en) | Serinic protease inhibitors | |
| IL132630A0 (en) | Protease inhibitors | |
| EP1093367A4 (de) | Proteaseinhibitoren | |
| IL132629A0 (en) | Protease inhibitors | |
| IL132088A0 (en) | Protease inhibitors | |
| ZA988479B (en) | Protease inhibitors | |
| EP1067894A4 (de) | Protheaseinhibitoren | |
| IL139187A0 (en) | Cysteine protease inhibitors | |
| EP1079821A4 (de) | Protease inhibitoren | |
| EP1235577A4 (de) | Proteaseinhibitoren | |
| AU1393900A (en) | Morpholino-ethoxybenzofuran protease inhibitors | |
| GB9800817D0 (en) | Serine protease inhibitors | |
| EP1232155A4 (de) | Protease inhibitoren | |
| EP1086083A4 (de) | Proteaseinhibitoren | |
| ZA988064B (en) | Protease inhibitors | |
| EP1229912A4 (de) | Proteaseinhibitoren | |
| EP1231921A4 (de) | Proteaseinhibitoren | |
| EP1229915A4 (de) | Proteasehemmer | |
| EP1229914A4 (de) | Proteasehemmer | |
| AU2713100A (en) | Protease inhibitors | |
| EP1161237A4 (de) | Protease-inhibitoren | |
| EP1233771A4 (de) | Proteasehemmer | |
| EP1229911A4 (de) | Proteaseinhibitoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20010710 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20020219 |
|
| AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7C 07D 401/02 A, 7C 07D 401/14 B, 7C 07D 225/02 B, 7A 61K 31/33 B, 7A 61K 31/44 B, 7A 61K 31/47 B, 7A 61P 19/02 B, 7A 61P 19/10 B, 7C 07D 405/14 B, 7C 07D 401/12 B, 7A 61K 31/395 B |
|
| 17Q | First examination report despatched |
Effective date: 20020716 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20021127 |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1041690 Country of ref document: HK |